The Renal Sympathetic Denervation Case was performed at the Mount Sinai Hospital Electrophysiology lab and transmitted live via satellite transmission to the 2nd Annual AF Innovations Conference, held November 30 – December 1, 2012, in New York City.

The interactive case, recorded in real-time, will demonstrate adjunctive renal sympathetic denervation to modify hypertension as upstream therapy in the treatment of Atrial Fibrillation.

Case Operators

Vivek Reddy, MD
Director, Cardiac Arrhythmia Service
Professor of Medicine
Mount Sinai School of Medicine
New York, NY

Jacob Koruth, MD
Associate Professor of Medicine
Mount Sinai School of Medicine
New York, NY

H-FIB Trial Purpose

The objective of the H-FIB trial is to determine the role of renal sympathetic denervation in the prevention of Atrial Fibrillation (AF) recurrence in patients with hypertension for whom a catheter-based AF ablation procedure is planned. Patients will be randomized to either AF catheter ablation (usual therapy) or AF catheter ablation plus renal sympathetic denervation.

The purpose of this study is to examine the potential additional benefit of performing renal sympathetic denervation at the same time as an AF ablation procedure, in order to improve the long-term success of the AF procedure.

Additional H-FIB Trial Information: http://clinicaltrials.gov/ct2/show/NCT01635998